Healthcare

CapVest Partners gets approval from FIRB to takeover Virtus Health (...

March 25, 2022 08:52 PM AEDT | By Aditi Saha

Highlights CapVest Partners has received confirmation from FIRB to buy Virtus Health. This follows an announcement by the company on 14 March 2022...

Incannex (ASX: IHL) signs term sheet to snap up APIRx Pharmaceutical...

March 24, 2022 05:34 PM AEDT | By Aditi Sarkar

A clinical-stage pharmaceutical company, Incannex Healthcare Limited (ASX: IHL) (Nasdaq: IXHL) has executed a term sheet with binding commercial terms...

ASX food and beverage stocks with highest 52-week return - GNC, LRK...

March 14, 2022 02:04 PM AEDT | By Aditi Sarkar

The term consumer staples represents a range of essential products used by customers. This group includes things like foods and beverages, household g...

From Metcash to Ansell: 5 ASX healthcare mid-cap shares in focus

February 16, 2022 01:37 PM AEDT | By Team Kalkine Media

On the Australian Securities Exchange (ASX), mid-cap stocks are the stocks whose market capitalisation ranges from AU$2 billion to AU$10 billion, i.e....

Imugene Secures Option Underwriting Agreement with Bell Potter to Ra...

September 10, 2020 12:50 PM AEST | By Team Kalkine Media

NSW-headquartered clinical stage immuno-oncology firm, Imugene Limited (ASX:IMU) has secured an underwriting agreement with Bell Potter Securities Lim...

SUDA Secures Australian Patent Office’s Approval on Anagrelide Cance...

September 09, 2020 02:17 PM AEST | By Team Kalkine Media

Summary SUDA’s share price soared by ~12% on securing approval for anagrelide cancer patent in Australia. With the Australian Patent Office...

Imugene Attains First US Ethics Approval from WIRB to Begin PD1-Vaxx...

September 08, 2020 12:59 PM AEST | By Team Kalkine Media

Australia-based immuno-oncology company Imugene Limited (ASX:IMU) has recently marked a great leap forward by attaining the first ethics approval in t...

ASX Share Price to Watch - Telix Pharmaceuticals; announces prostate...

September 05, 2020 12:15 AM AEST | By Team Kalkine Media

Summary ASX-listed biopharmaceutical player Telix Pharmaceuticals announced a strategic collaboration agreement with Palo Alto-based Varian Medical...

Noxopharm to Commence Veyonda<sup>®</sup>’s Clinical Trial in COVID-...

September 04, 2020 01:45 PM AEST | By Team Kalkine Media

Australian biotech, Noxopharm Limited (ASX:NOX) has announced an important milestone with formal approval for immediate initiation of Veyonda®&rsq...

Imugene’s FY20 Report Card Out, Outlines Notable Operational Achieve...

September 02, 2020 01:20 PM AEST | By Team Kalkine Media

In a latest update, the biotech company Imugene Limited (ASX:IMU) has published its Annual Report for the year ended 30th June 2020 on the ASX. The fi...

Scan Through SUDA’s Key Operational Achievements in FY 2019-2020

August 31, 2020 08:29 PM AEST | By Team Kalkine Media

Summary SUDA reported key operational achievements for FY 2019-2020. The Company finalised a key agreement with Cann Pharma Australia during the y...

Australian Cannabis Sector’s Growth Continues; Lens on Althea and MG...

August 30, 2020 12:10 AM AEST | By Team Kalkine Media

The Australian cannabis industry is growing continuously dodging the impact of COVID-19 pandemic. The cannabis industry in Australia will be able to e...

ASX 200 Pharma Player Set to Race into the Mighty US Market, With a...

August 28, 2020 11:10 PM AEST | By Team Kalkine Media

A recent ASX200 entrant midcap pharma company, aggressively cutting costs as it prepares to take its drug RYONCIL™ into the mighty US healthcare...

PTX Solidifies Balance Sheet Further: Announces A$7 million Placemen...

August 26, 2020 07:51 PM AEST | By Team Kalkine Media

On 26 August 2020, Prescient Therapeutics Limited (ASX:PTX) announced that it has received firm commitments to raise A$7,046,084 (before costs) by way...

Imugene Receives Third Ethics Approval for PD1-Vaxx’s Phase 1 Trial...

August 24, 2020 12:32 PM AEST | By Team Kalkine Media

The stock of Australian clinical-stage immuno-oncology company, Imugene Limited (ASX:IMU) traded ~1.8 per cent higher on 21st August 2020 following th...

Needle on CardieX Limited: What's Driving the Impressive Stock Perfo...

August 23, 2020 12:15 AM AEST | By Hina Chowdhary

Global health technology company, CardieX Limited (ASX:CDX) has experienced a stupendous price rally with a six-month investor return of more than 107...

E-health Services - the Apparent Next Step Amid Digital Boom and Pan...

August 22, 2020 01:28 AM AEST | By Team Kalkine Media

Summary Australian government intends to develop a national approach for digital health; however, challenges are hampering the pace of development....

Is CSL share price still a buy this year?

August 19, 2020 04:01 PM AEST | By Team Kalkine Media

Summary Biotech player CSL Limited announced its FY20 results with an impressive growth of 17% and 9% in net profit after tax and revenue, respecti...

Latest updates in healthcare space: Lens on EMD and AT1

August 16, 2020 12:34 AM AEST | By Kunal Sawhney

Since the onset of a pandemic, the health system of Australia has experienced both challenges and opportunities as a result of COVID-19. Many companie...

COVID-19: A Catastrophe For Most But A Boon For Some; Biotech Player...

August 16, 2020 12:32 AM AEST | By Team Kalkine Media

Summary Covid-19 pandemic appears to boost the market opportunity for biotech companies, mainly involved in the development of COVID-19 related tes...

5 ASX Companies Leveraging AI to Drive Growth in 2024

Markets